Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Sep 20;27(27):4515-21.
doi: 10.1200/JCO.2008.19.6873. Epub 2009 Aug 24.

Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer

Dezheng Huo  1 , Francis Ikpatt, Andrey Khramtsov, Jean-Marie Dangou, Rita Nanda, James Dignam, Bifeng Zhang, Tatyana Grushko, Chunling Zhang, Olayiwola Oluwasola, David Malaka, Sani Malami, Abayomi Odetunde, Adewumi O Adeoye, Festus Iyare, Adeyinka Falusi, Charles M Perou, Olufunmilayo I Olopade
Affiliations

Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer

Dezheng Huo et al. J Clin Oncol. .

Abstract

Purpose: Compared with white women, black women experience a disproportionate burden of aggressive breast cancer for reasons that remain unknown and understudied. In the first study of its kind, we determined the distribution of molecular subtypes of invasive breast tumors in indigenous black women in West Africa.

Patients and methods: The study comprised 507 patients diagnosed with breast cancer between 1996 and 2007 at six geographic regions in Nigeria and Senegal. Formalin-fixed and paraffin-embedded sections were constructed into tissue microarrays and immunostained with 15 antibodies. Five molecular subtypes were determined, and hierarchical cluster analysis was conducted to explore subgroups for unclassified cases.

Results: The mean (+/- standard deviation) age of 378 patients in the first cohort was 44.8 +/- 11.8 years, with the majority of women presenting with large (4.4 +/- 2.0 cm) high-grade tumors (83%) in advanced stages (72% node positive). The proportions of estrogen receptor (ER) -positive, progesterone receptor-positive, and human epidermal growth factor receptor 2 (HER2) -positive tumors were 24%, 20%, and 17%, respectively. Triple negativity for these markers was predominant, including basal-like (27%) and unclassified subtype (28%). Other subtypes were luminal A (27%), luminal B (2%), and HER2 positive/ER negative (15%). The findings were replicated in the second cohort of 129 patients. The unclassified cases could be grouped into a bad prognosis branch, with expression of vascular endothelial growth factor, B-cell lymphoma extra-large protein, and Cyclin E, and a good prognosis branch, with expression of B-cell lymphoma protein 2 and Cyclin D1.

Conclusion: These findings underscore the urgent need for research into the etiology and treatment of the aggressive molecular subtypes that disproportionately affect young women in the African diaspora.

PubMed Disclaimer

Conflict of interest statement

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

Figures

Fig 1
Fig 1
Hierarchical clustering of 378 invasive breast tumors from West Africa using 15 immunohistochemical markers. LumA, luminal A; LumB, luminal B; HER2, human epidermal growth factor receptor 2; ER, estrogen receptor; PR, progesterone receptor; EGFR, epidermal growth factor receptor; BCL2, B-cell lymphoma protein 2; VEGF, vascular endothelial growth factor; BCLXL, B-cell lymphoma extra-large protein; IGF-1R, insulin-like growth factor 1 receptor.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Smigal C, Jemal A, Ward E, et al. Trends in breast cancer by race and ethnicity: Update 2006. CA Cancer J Clin. 2006;56:168–183. - PubMed
    1. Eley JW, Hill HA, Chen VW, et al. Racial differences in survival from breast cancer: Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA. 1994;272:947–954. - PubMed
    1. Smith-Bindman R, Miglioretti DL, Lurie N, et al. Does utilization of screening mammography explain racial and ethnic differences in breast cancer. Ann Intern Med. 2006;144:541–553. - PubMed
    1. Newman LA, Griffith KA, Jatoi I, et al. Meta-analysis of survival in African American and white American patients with breast cancer: Ethnicity compared with socioeconomic status. J Clin Oncol. 2006;24:1342–1349. - PubMed
    1. Chlebowski RT, Chen Z, Anderson GL, et al. Ethnicity and breast cancer: Factors influencing differences in incidence and outcome. J Natl Cancer Inst. 2005;97:439–448. - PubMed

Publication types